Extending FDA-approved cancer drug indications requires high patient numbers, study finds Post author: Post published:September 29, 2023 Post category:uncategorized Number of patient participants needed for secondary approval of a new cancer drug. You Might Also Like Disruptions in liver and brain clocks contribute to unhealthy eating patterns November 7, 2024 Opportunities and limitations of using a large language model to respond to patient messages April 24, 2024 Simple biomarkers offer early warning of hidden heart risk in childhood cancer survivors January 11, 2024
Opportunities and limitations of using a large language model to respond to patient messages April 24, 2024
Simple biomarkers offer early warning of hidden heart risk in childhood cancer survivors January 11, 2024